Blättchen & Partner advises the management of Karo Healthcare
Karo Healthcare (“Karo”) a leading Pan-European Consumer health platform will change ownership following the announcement that EQT has agreed to sell Karo to funds managed by KKR, a leading global investment firm. The transaction marks a significant milestone in Karo’s journey, following a period of rapid transformation, geographic expansion, and strategic portfolio development.
The transaction is subject to customary regulatory conditions and approvals and is expected to close in the coming months. The financial details of the transaction were kept confidential by the parties.
Blättchen & Partner advised the management of Karo around the CEO Christoffer Lorenzen on the management participation program.
About Karo Healthcare
Karo is a leading pan-European consumer healthcare company headquartered in Stockholm, Sweden. The Company operates an attractive product portfolio spanning core categories such as Skin Health, Foot Health, and Intimate Health, as well as Digestive Health and Vitamins, Minerals & Supplements. During the past five years, Karo has scaled substantially, quadrupling in sales, building leading digital capabilities and establishing market presence to reach consumers in more than 90 countries with top brand positions across European markets. Karo employs about 470 people who work out of Karo’s 13 international hubs.
Blättchen & Partner has more than 25 years of expertise in advising and implementing management and employee participation programs in the context of private equity transactions, but also for listed and family-run companies as well as foundations and family offices. In addition, Blättchen & Partner supports the design of executive compensation models and acts as a compensation expert for listed corporations.
Blättchen & Partner GmbH
Briennerstr. 45 a-d
80333 München
Telefon: +49 (89) 21029460
Telefax: +49 (89) 21029466
http://www.blaettchen.de
Geschäftsführerin
Telefon: +49 (89) 210294-60
E-Mail: kw@blaettchen.de
